Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article
Advertisement

ResearchIn-Press PreviewCell biologyNephrology Open Access | 10.1172/jci.insight.196835

A TGF-β1/LEF1/β-catenin/JLP network motif regulates autophagy and tubule injury in renal fibrosis

Chen Li,1 Meng Zhang,1 Maoqing Tian,1 Zeyu Tang,1 Yuying Hu,1 Yuyu Long,1 Xiaofei Wang,1 Liwen Qiao,1 Jiefei Zeng,1 Yujuan Wang,1 Xinghua Chen,1 Cheng Chen,1 Xiaoyan Li,2 Lu Zhang,1 and Huiming Wang1

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Li, C. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Zhang, M. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Tian, M. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Tang, Z. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Hu, Y. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Long, Y. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Wang, X. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Qiao, L. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Zeng, J. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Wang, Y. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Chen, X. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Chen, C. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Li, X. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Zhang, L. in: PubMed | Google Scholar

1Department of Nephrology, Renmin Hospital of Wuhan University, Wuhan, China

2Department of Internal Medicine, Mayo Clinic, Rochester, United States of America

Find articles by Wang, H. in: PubMed | Google Scholar |

Published January 8, 2026 - More info

JCI Insight. https://doi.org/10.1172/jci.insight.196835.
Copyright © 2026, Li et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published January 8, 2026 - Version history
View PDF
Abstract

Sustained injury to renal tubular epithelial cells (TECs), driven by excessive autophagy, is a critical mechanism underlying kidney fibrosis. Our previous work identified JLP—a TEC-expressed scaffolding protein—as an endogenous anti-fibrotic factor that counteracts TGF-β1–induced autophagy and fibrogenesis. However, the mechanism underlying JLP downregulation in renal fibrosis remains unclear. Here, we delineated a TGF-β1/LEF1/β-catenin/JLP axis that governed TEC autophagy through a dichotomous regulatory circuit. Under physiological conditions, low levels of β-catenin and LEF1 with minimal nuclear localization permit normal JLP expression, which in turn maintains autophagy in check. In contrast, during renal injury, TGF-β1 promoted the expression and nuclear translocation of β-catenin and LEF1, which together suppressed JLP transcription. This loss of JLP-mediated inhibition led to unchecked autophagy and exacerbated fibrotic damage. Analyses of kidney tissues from patients with CKD, murine fibrotic kidneys, and cultured HK-2 cells confirmed consistent JLP downregulation accompanied by upregulation and nuclear accumulation of LEF1 and β-catenin. Therapeutic intervention using the β-catenin/LEF1 inhibitor iCRT3 or LEF1-targeted silencing in murine fibrosis models restored JLP expression, attenuated TEC autophagy, and ameliorated renal fibrosis. These findings revealed an autoregulatory circuit controlling TEC autophagy and fibrogenesis, and supported LEF1 and β-catenin as potential therapeutic targets in CKD.

Graphical Abstract
graphical abstract
Supplemental material

View Unedited blot and gel images

View

Version history
  • Version 1 (January 8, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts